Aggrecan degradation in osteoarthritis and rheumatoid arthritis.
Lark
M W
MW
Immunology and Inflammation Research, Merck Research Laboratories, Rahway, NJ, USA.
Bayne
E K
EK
Lohmander
L S
LS
D053674:Aggrecans; D000818:Animals; D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D002356:Cartilage / Q000378:metabolism; D011508:Chondroitin Sulfate Proteoglycans / Q000378:metabolism*; D016326:Extracellular Matrix Proteins; D006801:Humans; D037181:Lectins, C-Type; D008666:Metalloendopeptidases / Q000378:metabolism; D010003:Osteoarthritis / Q000378:metabolism*; D011509:Proteoglycans / Q000378:metabolism*; D013582:Synovial Fluid / Q000737:chemistry
D053674:Aggrecans; D011508:Chondroitin Sulfate Proteoglycans; D016326:Extracellular Matrix Proteins; D037181:Lectins, C-Type; D011509:Proteoglycans; D008666:Metalloendopeptidases